An animal experiment conducted by Feng et al. [68] found that PCSK9 triggers mitochondrial DNA damage and activates the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway in diabetic nephropathy, which can effectively reduce inflammation and delay its progression. This evidence concerns the gene STING1 and diabetic kidney disease.